The takeaway: berberine has a legitimate, research-backed role in supporting healthy blood sugar for people looking for a natural option, but it is not a diabetes treatment and should never replace prescribed medication
The global obesity GLP-1 market is valued at USD 8,169 million in 2025
Nauck MA, Wefers J, Meier JJ
Furthermore, the group treated with GLP-1-R agonists experienced fewer headache days than the other group while the dose of acetazolamide was reduced
Our team provides personalized and supervised GLP-1 therapy
Being a leader in microneedling TDDS, their unique micro needle technology, DEN (Droplet Extension Needle), allows them to transfer drugs through a soluble micro needle. Raphas has FDA cGMP manufacturing validation for microneedle skin patches and has completed Phase 1 clinical trials